Blog

Meet the partner: Sphereon

May 18, 2021
By
In

Today, we’d like to introduce our close partner Sphereon, a software development company specialized in the integration of enterprise content management systems and their business processes with blockchain technology. Together with Sphereon, Triall developed its first ecosystem application Verial eTMF: a blockchain-integrated document management solution that enables clinical trial professionals to generate verifiable proofs of their trial-related documents. Sphereon’s deep knowledge of blockchain, digital […]

Meet the Triall team: Rob

May 7, 2021
By
In

Every week Triall introduces one of its core team members. This week, we introduce Triall co-founder and general counsel Rob Posthumus! Rob has a legal background of 30+ years in finance/insurance, transport, and healthcare/higher education. In the healthcare sector, he also held several management functions. Through his involvement with technology transfer within Erasmus MC he […]

Meet the Triall team: Linda

April 30, 2021
By
In

Every week Triall introduces one of its core team members. This week, we introduce Triall co-founder and CFO Linda van de Burgwal! Dr. Linda van de Burgwal is an academic entrepreneur, with over 10 years of experience in entrepreneurship, consulting, research, and education in health and life sciences. Educated in the biomedical sciences, she holds […]

Stakeholders in the Triall Ecosystem

April 26, 2021
By
In,

Triall is laying the groundwork for the world’s first, blockchain-enabled digital ecosystem for clinical trials. It aims to consolidate activities of clinical trial professionals around the globe and across traditional organizational boundaries, while optimizing data integrity and security. In this article, we’ll cover some of the key stakeholders, their roles, and interactions in the Triall […]

Meet the Triall team: Ray

April 23, 2021
By
In

Every week Triall introduces one of its core team members. This week, we introduce Triall co-founder and Head of Marketing Raymond van der Waal! Ray has a background in biomedical sciences and in management & entrepreneurship within the Life Sciences. Over the past 4 years, he built experience as a researcher, consultant, and entrepreneur. His […]

Triall announces the release of the Triall Whitepaper 2.0

April 22, 2021
By
In,

Today, Triall announces the official release of the 2.0 version of the Triall whitepaper! This new version reflects our latest insights, plans, and vision for building towards the world’s first, blockchain-enabled digital ecosystem for clinical trials. An ecosystem that will comprise a multi-sided platform of modular, complementary, and interoperable software solutions for all types of […]

Introducing the Triall Community Fund

April 20, 2021
By
In,

At Triall, we truly believe that to build and grow a sustainable ecosystem, community engagement and bottom-up initiatives are key. We will engage stakeholders and community members in the decision-making process and governance of the ecosystem, by putting topics up for voting and through our investment vehicle the Triall Community Fund (TCF), which will comprise […]

Meet the Triall team: Mark

April 16, 2021
By
In

Every week Triall introduces one of its core team members. This week, we introduce Triall co-founder and Head of Product Design Mark van der Waal! Mark is an academic entrepreneur and management consultant who combines a thorough practical and academic background in health technology innovation. As a PhD candidate, he analyzes the dynamics of intangible resources and […]

Meet the Triall team: Joost

April 9, 2021
By
In

Every week Triall introduces one of its core team members. This week, we introduce Triall co-founder and Head of Clinical Affairs Joost Flach! Joost has worked in various positions within the contract research industry. He is an experienced clinical project manager and research scientist, through which he manages and consults on clinical trials for industry […]

Triall pre-sale details & token allocation

April 7, 2021
By
In,

Triall has opened up its pre-sale for investors that can provide considerable value to our ecosystem. In this article, we’d like to provide you with more info on our pre-sale rounds and overall token allocation. Triall will offer 52% of the total TRL token supply to the community through its Initial Token Offering (ITO) and […]